# Fox Chase Cancer Center

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/fox-chase-cancer-center/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 63.9 |
| Citations | 3,555,051 |
| City | Philadelphia |
| Country | US |
| Description | Fox Chase Cancer Center is a research organisation in Philadelphia, US. OpenAlex records 23,491 works and 3,555,051 citations for it. 3,447 researchers list it as their most recent affiliation. |
| Homepage | https://www.foxchase.org/ |
| OpenAlex ID | https://openalex.org/I1289437631 |
| Researchers | 3,447 |
| ROR ID | https://ror.org/0567t7073 |
| Type | healthcare |
| Wikidata ID | https://www.wikidata.org/wiki/Q5476635 |
| Works | 23,491 |

## University papers

Showing 12 of 154.

- [Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer](https://scholariq.org/papers/nivolumab-versus-docetaxel-in-advanced-nonsquamous-non-small-cell-lung-cancer/)
- [Integrated genomic analyses of ovarian carcinoma](https://scholariq.org/papers/integrated-genomic-analyses-of-ovarian-carcinoma/)
- [Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019](https://scholariq.org/papers/global-regional-and-national-burden-of-stroke-and-its-risk-factors-1990-2019-a/)
- [Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma](https://scholariq.org/papers/nivolumab-versus-everolimus-in-advanced-renal-cell-carcinoma/)
- [Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study](https://scholariq.org/papers/tamoxifen-for-prevention-of-breast-cancer-report-of-the-national-surgical/)
- [Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019](https://scholariq.org/papers/estimation-of-the-global-prevalence-of-dementia-in-2019-and-forecasted/)
- [International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma](https://scholariq.org/papers/international-association-for-the-study-of-lung-cancer-american-thoracic-society/)
- [Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma](https://scholariq.org/papers/nivolumab-plus-ipilimumab-versus-sunitinib-in-advanced-renal-cell-carcinoma/)
- [Global, regional, and national burden of stroke, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016](https://scholariq.org/papers/global-regional-and-national-burden-of-stroke-1990-2016-a-systematic-analysis/)
- [Concurrent Chemotherapy and Radiotherapy for Organ Preservation in Advanced Laryngeal Cancer](https://scholariq.org/papers/concurrent-chemotherapy-and-radiotherapy-for-organ-preservation-in-advanced/)
- [Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden](https://scholariq.org/papers/nivolumab-plus-ipilimumab-in-lung-cancer-with-a-high-tumor-mutational-burden/)
- [Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study](https://scholariq.org/papers/causes-of-blindness-and-vision-impairment-in-2020-and-trends-over-30-years-and/)

## University researchers

- [Martin J. Edelman](https://scholariq.org/researchers/martin-j-edelman/)
- [Suzanne M. Miller](https://scholariq.org/researchers/suzanne-m-miller/)
- [Parth Desai](https://scholariq.org/researchers/parth-desai/)
- [Marcin Chwistek](https://scholariq.org/researchers/marcin-chwistek/)
- [Erin K. Tagai](https://scholariq.org/researchers/erin-k-tagai/)
- [Mengying Deng](https://scholariq.org/researchers/mengying-deng/)

## University top topics

Showing 8 of 25.

- [Advanced Radiotherapy Techniques](https://scholariq.org/topics/advanced-radiotherapy-techniques/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Prostate Cancer Diagnosis and Treatment](https://scholariq.org/topics/prostate-cancer-diagnosis-and-treatment/)
- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Renal cell carcinoma treatment](https://scholariq.org/topics/renal-cell-carcinoma-treatment/)
- [BRCA gene mutations in cancer](https://scholariq.org/topics/brca-gene-mutations-in-cancer/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.